UFC® and Smith+Nephew announce multi-year extension of partnership
Smith+Nephew (NYSE:SNN) and UFC announced a multi-year extension of their worldwide marketing partnership on October 22, 2025, with Smith+Nephew remaining UFC’s Preferred Sports Medicine Technology Partner.
The renewal continues branded activations at major UFC events, athlete integrations, and an education program: the second Smith+Nephew UFC Combat Sports Medicine Course will be held in Las Vegas from February 18-20, 2026. The partnership highlights Smith+Nephew sports medicine technologies, including the REGENETEN and CARTIHEAL AGILI-C implants, and cites athlete ambassadors who received treatment with the company’s technologies.
Smith+Nephew (NYSE:SNN) e l'UFC hanno annunciato una estensione pluriennale della loro partnership di marketing a livello mondiale il 22 ottobre 2025, con Smith+Nephew che resta il Partner tecnologico di medicina sportiva preferito dell'UFC.
Il rinnovo prosegue con attivazioni di branding negli eventi UFC principali, integrazioni di atleti e un programma di formazione: il secondo Corso di Medicina delle Arti Marziali UFC di Smith+Nephew si terrà a Las Vegas dal 18 al 20 febbraio 2026. La partnership mette in evidenza le tecnologie di medicina sportiva di Smith+Nephew, tra cui gli impianti REGENETEN e CARTIHEAL AGILI-C, citando anche gli ambasciatori-atleti che hanno ricevuto trattamenti con le tecnologie dell'azienda.
Smith+Nephew (NYSE:SNN) y UFC anunciaron una extensión multianual de su asociación mundial de marketing el 22 de octubre de 2025, con Smith+Nephew manteniéndose como Socio tecnológico preferente de medicina deportiva de UFC.
La renovación continúa con activaciones de marca en los principales eventos de UFC, integraciones de atletas y un programa educativo: el Segundo Curso de Medicina Deportiva de Combate de UFC de Smith+Nephew se celebrará en Las Vegas del 18 al 20 de febrero de 2026. La asociación destaca las tecnologías de medicina deportiva de Smith+Nephew, incluidas las implantes REGENETEN y CARTIHEAL AGILI-C, y cita a embajadores atletas que recibieron tratamiento con las tecnologías de la empresa.
Smith+Nephew (NYSE:SNN)와 UFC는 전 세계 마케팅 파트너십의 다년간 연장을 2025년 10월 22일에 발표했으며, Smith+Nephew는 UFC의 선호 스포츠의학 기술 파트너로 남게 됩니다.
갱신은 주요 UFC 이벤트에서의 브랜드 활성화, 선수 협업, 교육 프로그램을 지속합니다: Smith+Nephew UFC 전투 스포츠 의학 과정의 두 번째 과정이 2026년 2월 18-20일 라스베이거스에서 개최될 예정입니다. 파트너십은 REGENETEN 및 CARTIHEAL AGILI-C 임플란트를 포함한 Smith+Nephew의 스포츠 의학 기술을 강조하고, 회사 기술로 치료를 받은 선수 홍보대사를 언급합니다.
Smith+Nephew (NYSE:SNN) et l'UFC ont annoncé une prolongation pluriannuelle de leur partenariat mondial de marketing le 22 octobre 2025, Smith+Nephew restant Partenaire technologique de médecine du sport privilégié par l'UFC.
Le renouvellement se poursuit avec des activations de marque lors des grands événements UFC, des intégrations d'athlètes et un programme éducatif: le deuxième Cours de médecine des sports de combat UFC de Smith+Nephew se tiendra à Las Vegas du 18 au 20 février 2026. Le partenariat met en lumière les technologies de médecine du sport de Smith+Nephew, notamment les implants REGENETEN et CARTIHEAL AGILI-C, et cite des ambassadeurs athlètes ayant reçu des traitements avec les technologies de l'entreprise.
Smith+Nephew (NYSE:SNN) und UFC kündigten eine mehrjährige Verlängerung ihrer weltweiten Marketingpartnerschaft am 22. Oktober 2025 an, wobei Smith+Nephew weiterhin UFCs bevorzugter Partner für Sportmedizin-Technologie bleibt.
Die Erneuerung setzt gebrandete Aktivierungen bei großen UFC-Veranstaltungen, Athleten-Integrationen und ein Bildungsprogramm fort: Der zweite Smith+Nephew UFC-KAMPFSPORTMEDIZIN-KURS findet in Las Vegas vom 18.-20. Februar 2026 statt. Die Partnerschaft hebt Smith+Nephew Sportmedizin-Technologien hervor, darunter Implantate REGENETEN und CARTIHEAL AGILI-C, und nennt Athleten-Botschafter, die Behandlungen mit den Technologien des Unternehmens erhalten haben.
Smith+Nephew (NYSE:SNN) و UFC أعلنا عن تمديد متعدد السنوات لشراكتهما العالمية في التسويق في 22 أكتوبر 2025، مع بقاء Smith+ Nephew كشريك تكنولوجيا الطب الرياضي المفضل لدى UFC.
يستمر التحديث في Activations الماركة في فعاليات UFC الكبرى، وتكاملات الرياضيين، وبرنامج تعليمي: سيعقد الدورة الثانية لطب الرياضة القتالية UFC من Smith+Nephew في لاس فيغاس من 18-20 فبراير 2026. تسلط الشراكة الضوء على تقنيات طب الرياضة من Smith+Nephew، بما في ذلك الزرعتين REGENETEN و CARTIHEAL AGILI-C، وتذكر سفراء رياضيين تلقوا علاجاً باستخدام تقنيات الشركة.
Smith+Nephew (NYSE:SNN) 与 UFC 宣布于全球市场营销合作关系的多年度延长，日期为2025年10月22日，Smith+Nephew 仍然是 UFC 的 首选运动医疗科技合作伙伴。
续约将继续在主要 UFC 赛事中的品牌活动、运动员整合以及教育项目：第二届 Smith+Nephew UFC 格斗运动医学课程将于2026年2月18-20日在拉斯维加斯举行。此次合作突出 Smith+Nephew 的运动医学科技，包括 REGENETEN 和 CARTIHEAL AGILI-C 移植物，并提及使用该公司科技接受治疗的运动员大使。
- None.
- None.
Insights
Renewal extends global marketing reach and athlete integration for Smith+Nephew with repeat medical education and event activation.
The extension keeps Smith+Nephew as the UFC's Preferred Sports Medicine Technology Partner, preserving a platform to showcase its Sports Medicine portfolio and athlete-case storytelling at major events. Continued access to UFC athletes and event activations supports brand visibility in combat-sports audiences and clinical stakeholders who follow athlete care stories.
Dependencies include effective activation at marquee events, measurable engagement from both the combat-sports community and surgical audiences, and successful execution of the repeat medical education course in Las Vegas on
Smith+Nephew to continue as UFC’s Preferred Sports Medicine Technology Partner
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world’s premier mixed martial arts organization, have announced a multi-year extension of their landmark worldwide marketing partnership forged in 2024.
Under the renewal, Smith+Nephew will continue as UFC’s Preferred Sports Medicine Technology Partner, a designation it received as UFC’s inaugural partner in that category, to activate its brand around some of UFC’s biggest events.
“The continued growth of this partnership is a positive development for combat sports,” said Robby Miller, Vice President, U.S. Global Partnerships, TKO. “Our initial collaboration has led to meaningful conversations with the combat sports community about advancements in health and safety using Smith+Nephew technology. We’re confident that together we’ll continue to play a part in making this sport safer for athletes and fans.”
“We are thrilled to continue our collaboration with UFC as their Preferred Sports Medicine Technology Partner focused on injury prevention, repair and recovery,” said Scott Schaffner, President of Global Sports Medicine for Smith+Nephew. “The global reach of UFC continues to provide us with an unmatched platform to highlight our advanced portfolio of Sports Medicine technology solutions designed to help treat anyone who suffers from an activity-related injury and get back to doing what they love.”
A true highlight of the initial agreement was a first-of-its-kind medical education course hosted by Smith+Nephew and UFC for treatment of injuries in combat sport athletes. Chaired by Dr. Michael Banffy from the Cedars-Sinai Kerlan-Jobe Institute in Los Angeles, the Smith+Nephew UFC Combat Sports Medicine Course featured a roster of world-renowned medical experts gathered to discuss current trends and techniques for treating combat sports injuries.
In addition to leading physician faculty, special guest presenters included UFC Hall of Famer and former UFC Light Heavyweight Champion Chuck ‘The Iceman’ Liddell, and former UFC Featherweight Champion and current UFC BMF Champion Max ‘Blessed’ Holloway.
Sports Medicine surgeons who missed the first iteration of the course will have another opportunity next year, as the second Smith+Nephew UFC Combat Sports Medicine Course will be held in Las Vegas, Nevada from February 18-20, 2026. Surgeons interested in attending should contact their Smith+Nephew representative.
Another key element of the partnership is that UFC offers Smith+Nephew the flexibility to integrate UFC athletes throughout its marketing efforts, providing opportunities for select UFC personalities to represent the brand. In 2024, UFC Heavyweight Champion Tom Aspinall served as Smith+Nephew brand ambassador, while in 2025, fan favorite Dustin “The Diamond” Poirier filled that important role. Both have had injuries treated using Smith+Nephew technology - aiding their recovery and return to active competition.
Smith+Nephew offers world-class Sports Medicine solutions including advanced technologies, instruments and implants that enable surgeons to perform minimally invasive surgery including the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip and small joints. Recent advancements in its biological healing portfolio include the REGENETEN◊ Bioinductive Implant for rotator-cuff repair and the CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant. Both technologies are transforming the way healthcare professionals treat soft tissue repair and actively improving patient outcomes versus the current standard of care.1-2
- ends –
Media Enquiries
Dave Snyder +1 (978) 749-1440
Smith+Nephew david.snyder@smith-nephew.com
References
- Altschuler N, Zaslav KR, Di Matteo B, et al. Aragonite-Based Scaffold Versus Microfracture and Debridement for the Treatment of Knee Chondral and Osteochondral Lesions: Results of a Multicenter Randomized Controlled Trial. Am J Sports Med. 2023;51(4):957-967. doi:10.1177/03635465231151252
- Ruiz Ibán MA, Navlet MG, Marco SM, et al. Augmentation of a transosseous equivalent repair in posterosuperior non-acute rotator cuff tears with a bioinductive collagen implant decreases the re-tear rate at one year. A randomised controlled trial. Arthroscopy. Published online 12/27/2023.
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 17,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook.
About UFC®
UFC® is the world’s premier mixed martial arts organization (MMA), with more than 700 million fans and approximately 318 million social media followers. The organization produces more than 40 live events annually in some of the most prestigious arenas around the world while distributing programming to more than 950 million broadcast and digital households across more than 210 countries and territories. UFC’s athlete roster features the world’s best MMA athletes representing more than 75 countries. The organization’s digital offerings include UFC FIGHT PASS®, one of the world’s leading streaming services for combat sports. UFC is part of TKO Group Holdings (NYSE: TKO) and is headquartered in Las Vegas, Nevada. For more information, visit UFC.com and follow UFC at Facebook.com/UFC and @UFC on X, Snapchat, Instagram, and TikTok: @UFC.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.
◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.
FAQ
What did Smith+Nephew announce about its UFC partnership on October 22, 2025 (SNN)?
When and where is the Smith+Nephew UFC Combat Sports Medicine Course in 2026?
How will the Smith+Nephew–UFC renewal affect athlete marketing and brand integration (SNN)?
Which Smith+Nephew sports medicine technologies are highlighted in the October 22, 2025 announcement?
Can surgeons attend the Smith+Nephew UFC Combat Sports Medicine Course in 2026 and how do they register?
Which UFC fighters previously served as Smith+Nephew brand ambassadors mentioned in the SNN release?
